A look at what is on the board for today Nothing significant on the board for today but there will be a couple of bigger ones to look out for in the week ahead.
<p>CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small
Leave a Comment